House report makes case for Medicare drug reference pricing

A House Ways and Means Committee report released Monday examines differentials between U.S. and foreign drug prices and concludes that “by all measures, U.S. consumers pay too high a price for drugs.”

For the 79

Read the full 346 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE